Dr. Christine Yang Finnin, MD

Dr. Finnin practices at Dermatologist Medical Group of North County, Inc in Oceanside, California.

Dr. Finnin's NPI, 1649683186, was assigned on June 3, 2014. Dr. Finnin graduated from SUNY Upstate Medical University in 2014. Dr. Finnin's New York license number on file is 294435.

Dr. Finnin's primary practice is Dermatologist Medical Group of North County, Inc, at 3613 Vista Way, Oceanside, CA 92056 in San Diego County. The practice phone is (760) 758-5340.

Dr. Finnin's primary practice is Dermatologist Medical Group of North County, Inc in Oceanside, California. The medical group on file is Dermatologist Medical Group of North County. Dmand AI also links Dr. Finnin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Finnin practices. Vendor and product names are available with a free account.

Dermatology is Dr. Finnin's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Finnin is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Finnin's licenses on file in 2 states: New York and California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, corns and calluses, facial skin infection, hives and itchy rashes among the conditions Dr. Finnin treats.

CMS data shows 6,000 Medicare services from Dr. Finnin across 23 procedure codes in 2024, for 1,138 Medicare patients. Medicare paid $285,609 for them. Every service was in an office.

CMS counts 1,138 Medicare patients who saw Dr. Finnin in 2024. The largest group is 65 to 74, with 494 patients. 72% of them have high cholesterol, and 60% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.00, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Finnin's median patient age at 62, with 63% women.

In 2024, Dr. Finnin wrote 941 Medicare Part D claims for 410 patients. 94% of them were for generic drugs. CMS names the drug for 767 of them, across 19 drugs with 11 or more claims each, at $54,605 in total drug cost. In 2023, CMS named 713 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Finnin for performance year 2024, reported as part of a group. Dr. Finnin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 741 procedures of skin biopsy by Dr. Finnin, more than 98% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Finnin in 2018. 2018 was the busiest year, with 2. Dr. Finnin's most frequent co-authors are Cynthia Chen, MD, Stephanie Marie Gallitano, MD and Rachel Severin Rigo, MD.

CMS Open Payments shows 301 general payments to Dr. Finnin from 28 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,620.

Dr. Finnin graduated from SUNY Upstate Medical University in 2014.

Dr. Finnin is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.